AR |
P10275
|
androgen receptor
|
Nuclear receptor
|
0.99 |
0.351 |
0.846 |
ARID1A |
O14497
|
AT-rich interaction domain 1A
|
|
1.00 |
0.455 |
0.846 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
BSG |
P35613
|
basigin (Ok blood group)
|
|
2.6E-05 |
0.458 |
0.769 |
C17orf97 |
Q6ZQX7
|
chromosome 17 open reading frame 97
|
|
4.8E-06 |
0.548 |
0.577 |
CAV1 |
Q03135
|
caveolin 1
|
Enzyme modulator
|
8.3E-03 |
0.388 |
0.885 |
CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
CD99 |
P14209
|
CD99 molecule (Xg blood group)
|
|
2.6E-03 |
0.491 |
0.731 |
CDK4 |
P11802
|
cyclin dependent kinase 4
|
Kinase
|
6.3E-02 |
0.412 |
0.808 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CKAP4 |
Q07065
|
cytoskeleton associated protein 4
|
|
0.51 |
0.436 |
0.731 |
CTAG1A |
P78358
|
cancer/testis antigen 1A
|
|
|
0.508 |
0.731 |
CTAG1B |
P78358
|
cancer/testis antigen 1B
|
|
|
0.507 |
0.731 |
CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
DICER1 |
Q9UPY3
|
dicer 1, ribonuclease III
|
Enzyme
|
1.00 |
0.446 |
0.846 |
DNMT3B |
Q9UBC3
|
DNA methyltransferase 3 beta
|
|
0.20 |
0.453 |
0.846 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
EZH2 |
Q15910
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
Epigenetic regulator
|
1.00 |
0.376 |
0.885 |
FEZ1 |
Q99689
|
fasciculation and elongation protein zeta 1
|
|
0.75 |
0.666 |
0.500 |
FHIT |
P49789
|
fragile histidine triad diadenosine triphosphatase
|
|
5.7E-03 |
0.444 |
0.846 |
GSTM1 |
P09488
|
glutathione S-transferase mu 1
|
|
2.1E-03 |
0.380 |
0.923 |